SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.
| Website | http://www.splice.bio |
| Employees | 59 (42 on RocketReach) |
| Founded | 2012 |
| Technologies |
JavaScript
,
HTML
,
PHP
+2 more
(view full list)
|
| Industry | Biotechnology, Drug Discovery |
| Keywords | Gene Therapy, Drug Discovery, Cell Therapy, Biotechnology Platform, Genetic Engineering, Therapeutic Proteins, Clinical Development, Genome Editing, Biotechnology Research, Biotechnology, Precision Medicine, Translational Research, Pharmaceutical Research, Molecular Biology, Next Generation Sequencing, Biopharmaceutical, Life Sciences |
| Competitors | Amgen, Regeneron, Evonik, Twist Bioscience, Codexis, Inc., Caribou Biosciences, Geno, Zymergen, Inc., Arzeda, Synthorx Inc +30 more (view full list) |
Looking for a particular SpliceBio employee's phone or email?
SpliceBio Questions
Miquel Vila-Perello is the CEO of SpliceBio.
42 people are employed at SpliceBio.
Top SpliceBio Employees
-
Miquel Vila-Perello
CEO at SpliceBio
Barcelona, CT, ES21 -
Sílvia Frutos
CTO at SpliceBio at SpliceBio
Barcelona, CT, ES2 -
Don Munoz
Chief Financial Officer at SpliceBio
Boston, MA, US15 -
Aniz Girach
Chief Medical Officer at SpliceBio
Leicester, GB2 -
Mathieu Streefland
SVP CMC at SpliceBio
Amsterdam, NH, NL32 -
2
-
Adrian Timmers
VP Pre Clin at SpliceBio
Burlington, MA, US25+ -
45+ -
Julian Esteve-Rudd
Director, Head of Ophthalmology at SpliceBio
Barcelona, CT, ES1 -
John Tobin
Vice President of Clinical Operations at SpliceBio
Reading, PA, US24
Related Companies
G2Crowd Trusted
300K+
Plugin Users
